The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcome of metastatic sarcomatoid renal cell carcinoma (sRCC): Results from the International mRCC Database Consortium.
Namita Chittoria
No relevant relationships to disclose
Hui Zhu
No relevant relationships to disclose
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Bayer/Onyx; Genentech; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Pfizer
Nils Kroeger
No relevant relationships to disclose
Jae-Lyun Lee
Honoraria - Bayer; Novartis; Pfizer
Research Funding - Bayer
Sandy Srinivas
No relevant relationships to disclose
Jennifer Knox
Consultant or Advisory Role - AVEO
Research Funding - Pfizer
Georg A. Bjarnason
No relevant relationships to disclose
Mary J. MacKenzie
Honoraria - Novartis; Pfizer
Lori Wood
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Ulka N. Vaishamayan
No relevant relationships to disclose
Neeraj Agarwal
No relevant relationships to disclose
Sumanta Kumar Pal
No relevant relationships to disclose
Min-Han Tan
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose
Takeshi Yuasa
No relevant relationships to disclose
Frede Donskov
Research Funding - Novartis
Scott A. North
No relevant relationships to disclose
Brian I. Rini
Consultant or Advisory Role - AVEO; Bayer/Onyx; Bristol-Myers Squibb; GlaxoSmithKline; Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer
Daniel Yick Chin Heng
Consultant or Advisory Role - Bayer; Novartis; Pfizer